Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2013
10/30/2013CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use
10/30/2013CN103373928A Compound for organic light-emitting diode, organic light-emitting diode including the same and flat panel display device
10/30/2013CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases
10/30/2013CN101535307B Triazole derivatives as kinase inhibitors
10/29/2013US8569506 Modified carbocyanine dyes and their conjugates
10/29/2013US8569504 Imidazopyridine compound
10/29/2013US8569501 Semiconductor materials and methods of preparation and use thereof
10/29/2013US8569500 Terrylene and quaterrylene derivatives
10/29/2013US8569494 Methods of synthesis and purification of heteroaryl compounds
10/29/2013US8569493 Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
10/29/2013US8569484 Heterocyclic urea derivatives and methods of use thereof
10/29/2013US8569338 Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds
10/29/2013US8569337 Tri-cyclic pyrazolopyridine kinase inhibitors
10/29/2013US8569318 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof
10/29/2013US8569316 Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
10/29/2013US8569295 Bicyclic urea compounds
10/29/2013US8569289 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
10/29/2013US8569283 Compounds and compositions as c-Kit kinase inhibitors
10/29/2013US8569282 Carboxamide compounds and their use
10/29/2013US8569281 Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK
10/29/2013US8568756 Inhibition of quorum sensing-mediated processes in bacteria
10/29/2013CA2563038C Neurologically-active compounds
10/24/2013WO2013159064A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/24/2013WO2013157622A1 Hiv replication inhibitor
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013157018A1 A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013156563A1 Quinone acceptors for photovoltaic use
10/24/2013WO2013156431A1 Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives
10/24/2013WO2013135671A9 Fungicidal pyrimidine compounds
10/24/2013US20130281699 Highly Pure Pyrroloquinolinyl-Pyrrole-2,5-Dione and Pyrroloquinolinyl-Pyrrolidine-2,5-Dione and Methods of Preparing Same
10/24/2013US20130281484 HDAC Inhibitors and Therapeutic Methods of Using Same
10/24/2013US20130281477 Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor
10/24/2013US20130281466 Arthropod pest control composition and method for controlling arthropod pests
10/24/2013US20130281463 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists
10/24/2013US20130281459 Heteroaromatic Aryl Triazole Derivatives as PDE10A Enzyme Inhibitors
10/24/2013US20130281449 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
10/24/2013US20130281442 Compounds for Treatment of Bovine Mastitis
10/24/2013US20130281433 Therapeutic compounds
10/24/2013US20130281399 Treatment of diseases by epigenetic regulation
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130281389 Novel drug targets to overcome de novo drug-resistance in multiple myeloma
10/24/2013US20130281359 New bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
10/24/2013US20130280245 3-Aryl-6-aryl-[1,2,4]triazolo[4,3-alpha]pyridines as Inhibitors of Cell Proliferation and the Use Thereof
10/24/2013CA2850881A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/23/2013EP2653505A1 Azo compound, ink composition, recording method and colored material
10/23/2013EP2651942A2 Electroactive 1,7 and 4,10- diazachrysene derivatives and devices made with such materials
10/23/2013EP2651941A1 Inhibitors of influenza viruses replication
10/23/2013EP2651940A1 Inhibitors of influenza viruses replication
10/23/2013EP2651939A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
10/23/2013EP2651938A1 Inhibitors of influenza viruses replication
10/23/2013EP2651937A1 Imidazo [4, 5 -c]quinolin- 1 -yl derivative useful in therapy
10/23/2013EP2651936A1 Azaindoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651935A1 Dyeing composition comprising a fatty substance, a pyrazolopyridine oxidation base and a coupler
10/23/2013EP2651934A1 Imidazopyridines as respiratory syncytial virus antiviral agents
10/23/2013EP2651933A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651932A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
10/23/2013EP2651922A1 Indoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
10/23/2013EP2651903A1 Benzimidazole respiratory syncytial virus inhibitors
10/23/2013EP2651891A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
10/23/2013EP2651888A1 New compounds for the treatment of neurodegenerative diseases
10/23/2013EP2651887A1 Novel compounds for the treatment of neurodegenerative diseases
10/23/2013CN103370378A Azo compound, ink composition, recording method and colored material
10/23/2013CN103370317A Imidazo [4, 5-c] quinolin-1-yl derivative useful in therapy
10/23/2013CN103370316A 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines as inhibitors of cell proliferation and the use thereof
10/23/2013CN103360392A Dolasetron mesylate compound
10/23/2013CN103360391A Novel apixaban crystal form and preparation method thereof
10/23/2013CN103360390A Pyrrocoline formylmethyl p-methane sulfonamide phenylethylamine derivative and its medical application
10/23/2013CN103360389A Phenolic hydroxyl contained phenanthroline derivative as well as preparation method and application thereof
10/23/2013CN103360388A 5-Amino-1,4-dihydro-1,8-naphthyridine derivatives and pharmaceutical compositions as well as uses thereof
10/23/2013CN103360387A Method for preparing compound zolpidem
10/23/2013CN103044423B Substituted pyridine-2-ketone compounds and preparation method thereof
10/23/2013CN102372712B Imidazodiazanaphthalene PI3K (phosphatidyl inositol 3 kinase) and mTOR (mammalian target of rapamycin) dual inhibitor
10/23/2013CN101723949B Polycyclic agents for treatment of respiratory syncytial virus infections
10/23/2013CN101679298B Fused bicyclic heteroaryl derivatives
10/23/2013CN101429198B Banisterine derivant and uses thereof
10/22/2013US8563730 Pyrazole and fused pyrazole glucokinase activators
10/22/2013US8563723 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
10/22/2013US8563722 Stereoselective hydrogenation of a ketone
10/22/2013US8563573 Azaindole derivatives as CFTR modulators
10/22/2013US8563570 Lactam compounds and their use as pharmaceuticals
10/22/2013US8563565 Pyrazoloquinoline derivatives
10/22/2013US8563562 Compounds having antiviral properties
10/22/2013US8563541 Azepine inhibitors of Janus kinases
10/22/2013CA2528179C Piperidinyl prostaglandin e analogs
10/22/2013CA2507807C Process for preparing optically pure proton pump inhibitors
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013153558A1 Anhydrous form of moxifloxacin hydrochloride
10/17/2013WO2013153535A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
10/17/2013WO2013153394A1 Quinolonones with antibacterial properties
10/17/2013WO2013152704A1 5-amino-1,4-dihydro-1,8-naphthyridine derivative and pharmaceutical composition and use thereof
10/17/2013WO2012104007A3 7-azaindole derivatives
10/17/2013US20130274475 Beta-lactamase inhibitors
10/17/2013US20130274474 1,3-oxathiolane derivatives, process for the preparation of 1,3-oxathiolane derivatives and intermediates thereof
10/17/2013US20130274452 Cyanine dyes and their conjugates
10/17/2013US20130274260 New compounds for the treatment of neurodegenerative diseases
10/17/2013US20130274259 Kinase modulation and indications therefor
10/17/2013US20130274258 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 646